Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2-aminoindane-2-carboxylic acid

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carboxylic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
In this study we present the synthesis and some pharmacological properties of nine new analogues of arginine vasopressin modified… Expand
2003
2003
Efficient synthesis of 2-aminoindane-2-carboxylic acid via dialkylation of nucleophilic glycine equivalent.
An efficient, easy to scale-up method for preparing 2-aminoindane-2-carboxylic acid via two-step alkylation of a Ni(II)-complex… Expand
1992
1992
New chemotactic peptide analogs with high biological activity for human neutrophils.
As a part of a research programme aimed at studying structure activity relationships in the field of chemotactic peptides… Expand
1991
1991
Synthesis and properties of chemotactic peptide analogs. I. Crystal structure and molecular conformation of HCO-Met-leu-Ain-OMe.
HCO-Met-Leu-Ain-OMe (2), an analog of the chemotactic peptide HCO-Met-Leu-Phe-OH, containing the conformationally blocked residue… Expand
1991
1991
Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
As a part of a research program aimed at studying structure activity relationship in the field of chemotactic peptides, modified… Expand
1948
1948
Synthesis of amino acids from substituted cyanoacetic esters.
Nine α-amino acids, namely, dl-alanine, dl-α-aminobutyric acid, dl-α-ammoenanthic acid, dl-α-amino-γ-phenoxybutyric acid, dl-C… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE